However, EndoCAb IgA and EndoCAb IgM levels were found to be reduced significantly in SLE patients treated with immunosuppressive drugs compared to untreated SLE patients (P = 0.035 & P = 0.025, respectively) (Figures 3E,F). This evidence concerns the gene CD79A and systemic lupus erythematosus.